Published 19:56 IST, November 12th 2020
Gates Foundation pledges another $70 million to ensure equal access to COVID-19 vaccine
The Gates Foundation, on November 11, added another $70 million to their fund which aims to support the development and distribution of vaccines and treatments
Advertisement
Gates Foundation, on vember 11, ded ar $70 million to ir fund which aims to support development and distribution of vaccines and treatments against COVID-19. latest donation by Bill and Melinda Gates led charity, has w taken fund’s total to $156 million. In a statement later, foundation said that it hopes that its action would prompt or big players to pledge more money for cause.
Fund distribution
As per a statement, ditional $50 million would go to COVAX vance Market Commitment (AMC) led by GAVI vaccine alliance. While ar $20 million would be credited to Coalition for Epidemic Preparedness Invations (CEPI) which was currently co-funding development of several COVID-19 vaccine candidates.
Advertisement
“COVID-19 anywhere is COVID-19 everywhere. That is why we have to ensure that everyone gets equal access to tests, drugs, and vaccines when y are available— matter where you live in world. Our pledge today, alongside generous commitments me by France, European Commission, and Spain, means we are getting closer to having resources needed to help world fight this virus. But we still have a long way to go," said Melinda Gates making anuncement.
Re: Very Large Portion Of COVID-19 Vaccines Likely To Be Manufactured In India: Gates Foundation CEO
Advertisement
Meanwhile, Mark Suzman, CEO of foundation has asserted that a very large portion of COVID-19 vaccines were likely to be manufactured in India through country's strong and robust private sector partners. In an interview to PTI, Suzman ted that India was doing everything it could right w with resources at hand to fight COVID-19 pandemic.
"I think India is doing everything it can right w with resources at hand, but we are all hopeful that next year as some of se vaccines should come out...and our expectation is that a very large portion of se are likely to be manufactured in India through strong and robust Indian private sector partners and n that will be key area to focus on in next phase of COVID pandemic,” he was quoted as saying by PTI.
Advertisement
Advertisement
19:57 IST, November 12th 2020